Trial
NCT03292536
Merestinib on Bone Metastases in Subjects With Breast Cancer
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Utah
Collaborators
Eli Lilly and Company
Condition
Bone Metastases
Intervention
Merestinib
Why stopped
Enrollment incomplete by the end of the contracted enrollment period
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-01-08